Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04030299 · ClinicalTrials.gov registry record · NA
Longitudinal Outcomes of Hearing Aids
A NA study, sponsored by Yu-Hsiang Wu.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04030299 is a NA study that has completed, run by Yu-Hsiang Wu. The registered enrollment target is 34 participants.
The verdict
NCT04030299, a NA study, has completed, sponsored by Yu-Hsiang Wu.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Age-related hearing loss is a substantial national problem due to its high prevalence and significant psychosocial consequences. Although hearing aids (HAs) are the primary intervention for the management of age-related hearing loss, only 15-30% of those who could benefit from HAs actually seek them out. HA adoption rates are even worse for people with lower income and for racial and ethnic minorities. One of the most commonly reported reasons for people not seeking HA intervention is the high cost of HAs and the associated audiological fitting services. Because HAs fitted using the audiologist-based service-delivery model are unaffordable, more and more Americans (1.5 million in 2010) purchase amplification devices via over-the-counter (OTC) service-delivery models to compensate for their impaired hearing. Although OTC amplification devices are gaining popularity and are regarded as an important option for promoting accessible and affordable hearing healthcare, it is unclear if they are viable solutions for age-related hearing loss as OTC models exclude professional services. Further, although there is some evidence supporting the effectiveness of OTC HAs, all previous studies measured short-term outcomes (e.g., 6 weeks). It is unknown what the long-term outcomes of OTC HAs would look like. The outcomes could improve across time because users may eventually figure out how to use HAs. On the other hand, the outcomes of OTC HAs could become poorer across time because, unlike traditional HA fitting, users do not have professionals to support them. Therefore, the overall goal of this project is to examine the longitudinal changes in OTC HA outcomes over 3 months.
Interventions
- DEVICE Over-the-counter fitting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04030299
The ClinicalTrials.gov registry entry for NCT04030299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yu-Hsiang Wu, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Over-the-counter fitting is the first listed.
NCT04030299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04030299 about?
NCT04030299 is a clinical study titled "Longitudinal Outcomes of Hearing Aids". Age-related hearing loss is a substantial national problem due to its high prevalence and significant psychosocial consequences. Although hearing aids (HAs) are the primary intervention for the management of age-related hearing loss, only 15-30% of those who could benefit from HAs actually seek them...
What is the current status of trial NCT04030299?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-09-01. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT04030299?
The interventions under investigation include: Over-the-counter fitting (DEVICE).
Who is sponsoring clinical trial NCT04030299?
This trial is sponsored by Yu-Hsiang Wu, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.